［1］Marques AC，Tan J，Ponting CP.Wrangling for microRNAs provokes much crosstalk［J］.Genome Biol，2011，12(11)：132.
[2]Lewis BP，Burge CB，Bartel DP.Conserved seed pairing，often flanked by adenosines，indicates that thousands of human genes are microRNA targets［J］.Cell，2005，120(1)：15-20.
[3]Wu K，He J，Pu W，et al.The role of exportin-5 in microRNA biogenesis and cancer［J］.Genomics Proteomics Bioinformatics，2018，16(2)：120-126.
[4]Siegel RL，Miller KD，Jemal A.Cancer statistics，2017［J］.CA Cancer J Clin，2017，67(1)：7-30.
[5]Dong HC，Zhai XF.The research progress on the mechanism of tumor angiogenesis-related signal proteins［J］.Modern Oncology，2014，22(9)：2231-2233.
[6]Wu J，Yuan P，Mao Q，et al.miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA［J］.Biochem Biophys Res Commun，2016，478(1)：274-278.
[7]Zhu Y，Tian Y，Du J，et al.Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration［J］.PLoS One，2012，7(5)：e37823.
[8]Mei J，Zhu YC.Research progress of the formin protein Daam1 and the metastasis of breast cancer［J］.Basic & Clinical Medicine，2019，39(2)：260-263.
[9]Mei J，Yan T，Huang Y，et al.A DAAM1 3′-UTR SNP mutation regulates breast cancer metastasis through affecting miR-208a-5p-DAAM1-RhoA axis［J］.Cancer Cell International，2019，19(1)：55.
[10]Xiong H，Yan T，Zhang W，et al.miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer［J］.Cell Signal，2018(44)：33-42.
[11]Song H，Wu T，Xie D，et al.WBP2 downregulation inhibits proliferation by blocking YAP transcription and the EGFR/PI3K/AKT signaling pathway in triple negative breast cancer［J］.Cell Physiol Biochem，2018，48(5)：1968-1982.
[12]Stanger BZ，Datar R，Murtaugh LC，et al.Direct regulation of intestinal fate by Notch［J］.Proc Natl Acad Sci USA，2005，102(35)：12443-12448.
[13]Ishibashi F，Shimizu H，Nakata T，et al.Contribution of ATOH1(+)cells to the homeostasis，repair，and tumorigenesis of the colonic epithelium［J］.Stem Cell Reports，2018，10(1)：27-42.
[14]Fukushima K，Tsuchiya K，Kano Y，et al.Atonal homolog 1 protein stabilized by tumor necrosis factor alpha induces high malignant potential in colon cancer cell line［J］.Cancer Sci，2015，106(8)：1000-1007.
[15]Yang X，Zhang L，Song X，et al.MicroRNA-613 promotes colon cancer cell proliferation，invasion and migration by targeting ATOH1［J］.Biochem Biophys Res Commun，2018，504(4)：827-833.
[16]Li B，Xie Z，Li Z，et al.MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer［J］.Am J Transl Res，2016，8(12)：5475-5484.
[17]Dong Y，Wei MH，Lu JG，et al.Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN［J］.Biomed Pharmacother，2019(109)：2035-2042.
[18]Matta A，Siu KW，Ralhan R.14-3-3 zeta as novel molecular target for cancer therapy［J］.Expert Opin Ther Targets，2012，16(5)：515-523.
[19]Jiang X，Wu J，Zhang Y，et al.MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ［J］.Gene，2018(659)：168-174.
[20]Sureban SM，Madhoun MF，May R，et al.Plasma DCLK1 is a marker of hepatocellular carcinoma(HCC)：Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism［J］.Oncotarget，2015，6(35)：37200-37215.
[21]WANG H，LIU B.Expression and significance of Doublecortin-like kinase 1 in the digestive system tumors［J］.Modern Oncology，2014，22(11)：2741-2743.［王欢，刘斌.Doublecortin-like kinase 1在消化系统肿瘤中的表达及意义［J］.现代肿瘤医学，2014，22(11)：2741-2743.］
[22]Wang W，Zhang H，Wang L，et al.miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1［J］.Biochem Biophys Res Commun，2016，473(4)：987-992.
[23]Wang Z，Zou Q，Song M，et al.NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression［J］.Biomed Pharmacother，2017(94)：612-618.
[24]Al-Saleh K，Quinton C，Ellis PM.Role of pemetrexed in advanced non-small-cell lung cancer：Meta-analysis of randomized controlled trials，with histology subgroup analysis［J］.Curr Oncol，2012，19(1)：e9-e15.
[25]Chan LW，Wang F，Meng F，et al.Multi-scale representation of proteomic data exhibits distinct microRNA regulatory modules in non-smoking female patients with lung adenocarcinoma［J］.Comput Biol Med，2018(102)：51-56.
[26]Morgan DO.Cyclin-dependent kinases：Engines，clocks，and microprocessors［J］.Annu Rev Cell Dev Biol，1997(13)：261-291.
[27]Pacheco J，Schenk E.CDK4/6 inhibition alone and in combination for non-small cell lung cancer［J］.Oncotarget，2019，10(6)：618-619.
[28]Li D，Li DQ，Liu D，et al.MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer［J］.Cellular Oncology，2016，39(2)：139-147.
[29]Jiang C，Yang Y，Yang Y，et al.Long noncoding RNA(lncRNA)HOTAIR affects tumorigenesis and metastasis of non-small cell lung cancer by upregulating miR-613［J］.Oncology Research，2018，26(5)：725-734.
[30]Chen X，Xu Y，Liao X，et al.Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer［J］.Tumour Biol，2016，37(9)：11927-11936.
[31]Zheng W，Feng Q，Liu J，et al.Inhibition of 6-phosphogluconate dehydrogenase reverses cisplatin resistance in ovarian and lung cancer［J］.Frontiers in Pharmacology，2017(8)：421.
[32]Li Q，Zhou L，Wang M，et al.MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14［J］.Biomedicine & Pharmacotherapy，2018(98)：636-642.
[33]Grimm D，Bauer J，Wise P，et al.The role of SOX family members in solid tumours and metastasis［J］.Semin Cancer Biol，2019，pii：S1044-579X(18)30141-X.doi：10.1016/j.semcancer.2019.03.004.
[34]LIU GS，ZHOU ZH，GUO XY，et al.Expressions of intestine-specific transcription factor CDX2 and SRY-related high mobility group-box gene 9(SOX9)in intestinal metaplasia and gastric cancer［J］.Modern Oncology，2017，25(5)：760-765.［刘贵生，周子涵，郭雪艳,等.同源盒转录因子CDX2与Y染色体决定因子SOX9在肠上皮化生及胃癌组织中的表达［J］.现代肿瘤医学，2017，25(5)：760-765.］
[35]Sang Q，Liu X，Sun D.Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9［J］.Onco Targets Ther，2018(11)：2429-2438.
[36]LU Y，TONG JP.The pathogenesis，diagnosis and treatment of retinoblastoma［J］.Modern Oncology，2016，24(6)：1007-1014.［陆烨，童剑萍.视网膜母细胞瘤的发生机制及诊断和治疗进展［J］.现代肿瘤医学，2016，24(6)：1007-1014.］
[37]Liban TJ，Thwaites MJ，Dick FA，et al.Structural conservation and E2F binding specificity within the retinoblastoma pocket protein family［J］.J Mol Biol，2016，428(20)：3960-3971.
[38]Zhang Y，Zhu X，Zhu X，et al.MiR-613 suppresses retinoblastoma cell proliferation，invasion，and tumor formation by targeting E2F5［J］.Tumor Biology，2017，39(3)：101042831769167.
[39]Yang G，Fu Y，Lu X，et al.LncRNA HOTAIR/miR-613/c-met axis modulated epithelial-mesenchymal transition of retinoblastoma cells［J］.J Cell Mol Med，2018，22(10)：5083-5096.
[40]Wang JX，Yang Y，Li K.Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9［J］.J Cell Physiol，2018，233(10)：6986-6995.
[41]Yu H，Duan P，Zhu H，et al.miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1［J］.Am J Transl Res，2017，9(3)：1213-1221.
[42]Sun D，Lu J，Hu C，et al.Prognostic role of miR-760 in hepatocellular carcinoma［J］.Oncol Lett，2018，16(6)：7239-7244.
[43]Zhu Y，Tang L，Zhao S，et al.CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by microRNA-613［J］.Cancer Sci，2018，109(8)：2412-2422.
[44]Li X，Sun X，Wu J，et al.MicroRNA-613 suppresses proliferation，migration and invasion of osteosarcoma by targeting c-MET［J］.Am J Cancer Res，2016，6(12)：2869-2879.
[45]Feng L，Yang B，Tang XD.Long noncoding RNA LINC00460 promotes carcinogenesis via sponging miR-613 in papillary thyroid carcinoma［J］.J Cell Physiol，2019，234(7)：11431-11439.
[46]Ren W，Li C，Duan W，et al.MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7［J］.Biochem Biophys Res Commun，2016，469(3)：633-638.
[47]Zhang X，Zhang H.Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer［J］.Eur Rev Med Pharmacol Sci，2016，20(5)：837-841.
[48]Li WT，Wang BL，Yang CS，et al.MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9［J］.Eur Rev Med Pharmacol Sci，2018，22(13)：4107-4114.
[49]Iman M，Mostafavi SS，Arab SS，et al.HOXB7 and Hsa-miR-222 as the potential therapeutic candidates for metastatic colorectal cancer［J］.Recent Pat Anticancer Drug Discov，2016，11(4)：434-443.